About Us
Home > About Us
Pediatric cellular therapies and transplants are among the most promising advancements in modern medicine, offering hope to children battling life-threatening diseases such as leukemia, thalassemia, and immune disorders. However, ensuring equitable access, high-quality treatment, and better patient outcomes requires an enabling ecosystem that promotes innovation, collaboration, and capacity building. The Society for Pediatric Cellular Therapy and Transplant (SPCTT) is committed to transforming pediatric care in India, and the world.
SPCTT’s primary goal is bridging research, clinical practice, and public health gaps. By facilitating collaboration among clinicians, researchers, pharma companies, and policymakers, SPCTT promotes the development of cutting-edge therapies for pediatric patients. Through workshops, conferences, and training programs, the organisation empowers healthcare providers with knowledge and skills required to deliver effective treatments.
SPCTT focuses on research and innovation in treatments like CAR-T cells and gene therapies. Through public-private partnerships, international collaborations, and leveraging global expertise, it ensures that Indian children benefit from the latest advancements.
With a vision to improve clinical outcomes in children suffering from difficult-to-treat, debilitating blood disorders, SPCTT is working towards making life-saving, advanced therapies accessible to every child.
SPCTT envisions a world where every child battling life-threatening diseases has access to cutting-edge cellular therapies and transplants. By fostering a robust ecosystem of innovation, collaboration, and capacity building, SPCTT aims to set global standards in pediatric care. Our vision is to create a future where advanced treatments are accessible to all, enabling children in India and beyond to lead healthier, happier lives while shaping a sustainable model of excellence in healthcare for generations to come.
SPCTT is dedicated to advancing pediatric cellular therapies and transplants by bridging the gaps between research, clinical practice, and public health. We strive to empower healthcare providers through education, by driving innovation in treatments like CAR-T cells and gene therapies, and facilitating global collaborations. By promoting equitable access and delivering high-quality care, we, at SPCTT, aim to transform the treatment options for children with life-threatening diseases, ensuring they receive state-of-the-art therapies for better outcomes.